- Home
- IBG vs IMCC Comparison
IBG vs IMCC Comparison
Compare IBG & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | IMCC |
|---|---|---|
| Founded | 2018 | 1980 |
| Country | Australia | Israel |
| Employees | 9 | N/A |
| Industry | Beverages (Production/Distribution) | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | IBG | IMCC |
|---|---|---|
| Price | $1.02 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 248.4K | ★ 604.9K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $63.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.23 |
| 52 Week High | $6.50 | $7.12 |
Technical Indicators
Market Signals| Indicator | IBG | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 36.56 | 31.06 |
| Support Level | $0.97 | N/A |
| Resistance Level | $1.31 | $0.55 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 6.52 | 14.53 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.